• 
• http://www.nature.com/tpj
• Editor: Professor Julio Licinio
• Volume 9: 6 issues per year
• ISSN: 1470-269X
• EISSN: 1473-1150
• Impact factor : 5.435*
• Impact ranking: 20/138 in Genetics & Heredity; 17/216 in Pharmacology & Pharmacy*
• Date Established: 2001
• Published on behalf of: International Society of Pharmacogenomics

Aims and Scope:
The Pharmacogenomics Journal is dedicated to the publication of original research on pharmacogenomics and its clinical applications.

Topics covered include:

• Identification of novel genomic targets for drug development
• Clinical applications of genomic science
• Potential benefits of pharmacogenomics
• Effects of genetic variability on drug toxicity and efficacy
• Pharmacokinetic variation and drug toxicity
• Pharmacodynamic variation and drug efficacy
• The integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics

Readership:
Geneticists, molecular biologists, clinical and molecular pharmacologists, as well as those working in biotechnology, drug discovery and drug development.

Online features and site license access:

• Online archive available back to January 2001.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content is freely available after five years.
• Indexed in Medline (PubMed), BIOSIS, Biotechnology Abstracts, Cambridge Scientific Abstracts, Chemical Abstracts Service and EMBASE.

*2008 Journal Citation Report (Thomson Reuters, 2009)